HIT Health In Tech, Inc.
Technology$0.87-3.57%ClosedMarket Cap: $46.6M
As of 2026-05-26
Valuation
P/E (TTM)
56.43
PEG
0.62
P/B
2.39
P/S
1.42
EV/EBITDA
-110615.21
DCF Value
$-0.72
FCF Yield
-2.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
58.9%
Operating Margin
-3.3%
Net Margin
-2.4%
ROE
-4.5%
ROA
-2.8%
ROIC
-3.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $8.8M | 51.4% | $-2.2M | $-1.6M | $— | — |
| Q4 null | $7.5M | 55.0% | $-170.8K | $-302.6K | $— | — |
| FY null | $33.3M | 62.8% | $1.5M | $1.3M | $— | — |
| Q3 null | $8.5M | 60.6% | $493.5K | $452.2K | $— | — |
| Q2 null | $9.3M | 67.7% | $725.1K | $630.6K | $— | — |
| Q1 null | $8.0M | 66.8% | $480.7K | $498.6K | $— | — |
| Q4 null | $4.9M | 77.4% | $-316.3K | $-144.2K | $— | — |
| FY null | $19.5M | 79.2% | $989.9K | $670.5K | $— | — |
| Q3 null | $4.5M | 78.0% | $438.9K | $376.1K | $— | — |
| Q2 null | $5.0M | 80.5% | $534.9K | $338.0K | $— | — |
| Q1 null | $5.1M | 80.7% | $332.4K | $100.5K | $— | — |
| Q4 2023 | $5.2M | 81.8% | $1.5M | $1.0M | $0.02 | — |